论文部分内容阅读
2012年4月,欧洲糖尿病研究协会(EASD)和美国糖尿病学会(ADA)联合发表关于2型糖尿病患者高血糖管理的立场声明,首次提出临床决策应以患者为中心,在第48届欧洲糖尿病研究协会年会(2012年10月,德国柏林),大会主办方对该声明做了重点推介。个体化干预策略以患者为中心管理策略被定义为“一种尊重并反映个体患者喜好、需求和价值的管理策略,确保患者的价值观指导所有的临床决策”。EASD和ADA强调,这应该是糖尿病患者(以及其他慢病)医疗保健的组织原则。鉴于在治疗类型和顺序上的不确定性,这种方法对2型糖尿病患者尤其适合。
In April 2012, the European Diabetes Research Association (EASD) and the American Diabetes Association (ADA) jointly issued a position statement on the management of hyperglycemia in patients with type 2 diabetes. It was the first time that clinical decision-making should be patient-centered. At the 48th European Diabetes Study Association annual meeting (October 2012, Berlin, Germany), the organizers of the conference made a key introduction to the statement. Individualized intervention strategy A patient-centered management strategy is defined as a “management strategy that respects and reflects the preferences, needs and values of individual patients and ensures that the patient’s values guide all clinical decisions.” EASD and ADA emphasize that this should be the organizing principle for health care for people with diabetes (and for other chronic diseases). In view of the type of treatment and the uncertainty of the order, this method is particularly suitable for patients with type 2 diabetes.